Introduction {#Sec1}
============

Septic shock is initiated by the release of bacterial cell wall-derived lipopolysaccharide. If left unchecked, this process may progress to refractory hypotension, multiple organ system failure, and death. Beyond refractory hypotension, oxygen-derived free radicals are believed to contribute to the cellular and tissue injuries associated with endotoxin-induced inflammation. Investigators have suggested that this oxidative damage may be a major cause of organ failure and mortality associated with sepsis \[[@CR1]\] and that the administration of antioxidants may be an adjuvant to conventional therapy (such as vasoconstrictors) in the management of sepsis \[[@CR2], [@CR3]\].

The heme oxygenases, which consist of inducible and constitutive isozymes (HO-1, HO-2), catalyze the rate-limiting step in the metabolic conversion of heme to the bile pigments (i.e., biliverdin and bilirubin) and thus constitute a major intracellular source of iron and carbon monoxide (CO) \[[@CR4]\]. HO-1 is a potentially important stress response protein. HO-1 is induced not only by the substrate heme but also by a variety of nonheme substance such as heavy metals, endotoxin, heat shock, cytokines, and prostaglandins \[[@CR4]\]. HO-1 and the subsequent metabolites of heme catabolism appear to play vital roles in regulating important biological responses, including inflammation, oxidative stress, cell survival, and cell proliferation \[[@CR4]\]. The proposed mechanisms by which HO-1 exerts its biological effects include its ability to degrade the pro-oxidative heme, the release of biliverdin and subsequent conversion to bilirubin, both of which have antioxidant properties^,^ and the generation of CO, which has vasodilatory, antiproliferative, and anti-inflammatory properties \[[@CR4]\]. At the same time, investigators have provided evidence that CO via the HO system may contribute to the regulation of systemic blood pressure and partially participate in the hypotensive response to LPS \[[@CR5]\]. However, which is more important in aforementioned two behaviors about HO-1 during septic shock is not very clear at present.

To better understand the role of HO-1 in the pathophysiology of septic shock, we evaluated LPS-induced shock and end-organ dysfunction in rats. The goal of the present study was to define the role of HO-1 in LPS-induced hypotension and to determine whether refractory hypotension and/or exaggerated oxidative stress was responsible for the mortality in septic shock rats by HO activity inhibitor treatment.

Methods {#Sec2}
=======

Animal studies {#Sec3}
--------------

Two-month-old male Sprague-Dawley rats (160--185 g) were purchased from the Laboratory Animal Center of Tongji Medical College. Only five animals were housed in the same cage, acclimatized to a 12-h light-dark cycle and allowed free access to food and water for a 5-day period prior to the experimental procedure. During the experiments, the environmental temperature was maintained between 23 and 25°C. The experimental protocol was approved by the local animal care and use committee, and all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23, revised 1985).

Rats were fasted for 12 h, but allowed free access to water before the induction of anesthesia. The rats received an intraperitoneal injection of 20% urethane (1.5 g/kg) that kept them anesthetized throughout the experiment. The right carotid artery and the intra-jugular vein were cannulated with PE-50 tubing to monitor the mean arterial pressure (MAP) using Hellige monitor instruments (Germany), and with a 24-g cannula for intravenous injections. Subsequently, the animals were heparinized with 500 U/kg heparin.

Eighty rats were randomly divided into four groups: C group (*n *= 20), Z group (*n *= 20), SS group (*n *= 20) and LZ group (*n *= 20). Groups C and Z received 0.5 ml normal saline intravenously, while groups SS and LZ both received 0.5 ml (10 mg/kg) LPS(O111B4, Sigma, USA) to replicate the experimental model of septic shock. After an initial 25% decrease in the MAP, group LZ received 1 ml (10 μmol/kg, intraperitoneally) zinc protoporphyrin-IX (ZnPP-IX, Sigma, USA), while group SS received 1 ml 50 mM sodium bicarbonate vehicle in place of ZnPP-IX. Two hours after injecting normal saline intravenously, group Z received 1 ml (10 μmol/kg, intraperitoneally) ZnPP-IX, while group C received 1 ml 50 mM sodium bicarbonate vehicle instead. The rats received 0.5 ml of 30 mg/kg Evans blue (EB, Serva, Germany) intravenously 5 min before administering the LPS or normal saline. MAP was monitored continuously, and if the MAP did not decrease within 2 h, the animal was excluded from the study.

Monitoring and recording indexes {#Sec4}
--------------------------------

MAP and ECG were monitored continuously throughout the experiment. The MAP was recorded after the induction of the septic shock at 30, 60, 90 and 120 min. And the deaths within 7 h were recorded.

Sampling and storage {#Sec5}
--------------------

The blood samples were collected 7 h after LPS administration in a living rat or in a dying rat having an ECG displaying HR ≤ 20 beats/min, or a ventricular flutter, or a ventricular fibrillation, and centrifuged at 4,000 rpm for 10 min at 4°C. The rats were killed, and their femoral artery, liver, lung, and kidney were removed, and quickly perfused with phosphate-buffered saline to remove the blood. The blood samples and the remaining tissues after perfusion and rinsing were frozen in liquid nitrogen and stored at −70°C until assayed.

Biochemical measurements {#Sec6}
------------------------

Alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine (Cr), and blood urea nitrogen (BUN) levels in the plasma were measured with a Hitachi7060 Fully Automated Biochemistry Analyzer (Japan). Hepatic, renal and pulmonary superoxide dismutase (SOD) activity, and malondialdehyde (MDA), contents were determined by spectrophotometry \[[@CR6]\] and by the method of Ohkawa et al. \[[@CR7]\], respectively. SOD activity and MDA contents were expressed as per unit of protein determined by the Lowry method \[[@CR8]\].

### Measurement of Evans blue contents {#Sec7}

The right lung was weighed and then incubated in formamide for 18 h at 37°C to extract the EB dye. The left lung was weighed and then dried in an oven at 55°C, and the wet-to-dry weight ratio from that lung was used to estimate the dry weight of the right lung. The extracted dye was quantitated in a spectrophotometer by measuring the absorbance at 620 nm and comparing to standards of EB dye dissolved in formamide. The EB dye extravasation was expressed as nanograms of EB dye per milligram of dry tissue.

### Measurement of CO in plasma {#Sec8}

CO level in plasma was determined by the method of Chalmers AH \[[@CR9]\], and was expressed as milligram of CO per liter of fresh blood.

RNA extraction and reverse transcription (RT)-PCR {#Sec9}
-------------------------------------------------

Total RNA was extracted from the femoral artery, liver, kidney, and lung by employing a Total Quick RNA kit (TA200TQR, Talent, Italy). The ethanol-precipitated RNA fraction (1 μg) was reverse transcribed using a Revert Aid^TM^ First Strand cDNA Synthesis kit (MetaBios Inc., Canada), according to the manufacturer's protocol, and 50 μL of first-strand cDNA solution was obtained. The primers used in this study were 5′-CGACAGCATGTCCCAGGATT-3′ and 5′-TCGCTCTATCTCCTCTTCCAGG-3′ for rat HO-1, 160 bp; 5′-TTCTACCTGTTCGAGCATGTGG-3′ and 5′-TGTTAGCATGGAGCCAGCCT-3′ for rat HO-2, 180 bp; 5′-CCTAAGGCCAACCGTAAAG-3′ and 5′-TCTTCATGGTGCTAGGAGCCA-3′ for rat ß-actin, 623 bp. RT-PCR was performed as described by Hidenori Suzuki et al. \[[@CR10]\]. The integral optical density (IOD) of the DNA bands was measured with a Shanghai Sixing Image Analysis System. The IOD ratio of HO-1,or HO-2, and ß-actin was calculated, and used as an expression of HO-1 mRNA or HO-2 mRNA.

Western blot analysis {#Sec10}
---------------------

Tissue samples were homogenized in 13.2 mmol/L Tris--HCl, 5.5% glycerol, 0.44% SDS, and 10% ß-mercaptoethanol. An equal amount of extracted soluble protein (50 μg) was fractionated by Tris--glycine--SDS--polyacrylamide gel (12%) electrophoresis, and Western blotting was performed as described \[[@CR11]\] with use of a polyclonal rabbit antibody to recombinant rat HO-1 or HO-2 protein (1:1,000, Santa Cruz, USA). The IOD of protein bands were measured with a LEICA-550IW Image Analysis System. The product of IOD and the area was as an expression of HO-1 protein (or HO-2 protein).

Statistical analysis {#Sec11}
--------------------

All data were expressed as mean ± standard deviation (SD). Comparisons of mortality between groups were made by the *χ*^2^ goodness of fit test, and intergroup comparisons among the four groups were determined by one-way ANOVA. When the *F* value was significant (*P *\< 0.05), a post hoc analysis was performed with the Duncan new multiple range test in order to test the difference between means. *P *\< 0.05 was considered statistically significant.

Results {#Sec12}
=======

Deaths {#Sec13}
------

The death rate in group SS (13 animals) was lower than that in the LZ group (19 animals) (*P *\< 0.05), and was higher than that in groups C (zero animal) and Z (zero animal) (all *P *\< 0.05), respectively. There was no significant difference in death rate between C group and Z group (*P *\> 0.05).

Comparisons of MAP {#Sec14}
------------------

The changes of MAP among the four groups are shown in Table [1](#Tab1){ref-type="table"}. Sixty minutes after septic shock, the MAP in the LZ group was significantly higher than that in the SS group (all *P *\< 0.05), and lower than that in groups C and Z (all *P *\< 0.05). There was no significant difference between the C group and the Z group (*P *\> 0.05).Table 1Changes of MAP by ZnPP-IX or NaHCO~3~ treatment in four groups $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
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\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ (\bar{x} \pm s,\;n = 20) $$\end{document}$Basic MAPBefore treatment MAP (mmHg)After treatment MAP (mmHg)30 min60 min90 min120 minC99.6 ± 12.298.1 ± 11.1\*97.1 ± 12.1\*97.8 ± 11.8\*98.6 ± 11.7\*99.1 ± 10.7\*Z100.1 ± 10.998.8 ± 10.5\*97.4 ± 11.3\*99.0 ± 10.6\*99.3 ± 10.5\*98.2 ± 12.7\*SS99.1 ± 11.772.2 ± 9.370.1 ± 9.267.1 ± 7.8\*65.1 ± 7.3\*63.4 ± 6.8\*LZ98.8 ± 11.572.8 ± 9.070.6 ± 8.572.3 ± 7.373.3 ± 6.974.5 ± 7.6\* Indicates test group significantly different from LZ group (one-way ANOVA, *P *\< 0.05)

Comparisons of CO, Cr and Bun concentrations, ALT and AST activities, and lung EB contents {#Sec15}
------------------------------------------------------------------------------------------

The comparisons of the CO, Cr and BUN concentrations, ALT and AST activities, and EB contents among four groups are shown in Table [2](#Tab2){ref-type="table"}. The CO concentration in group LZ was significantly lower than that in group SS (*P *\< 0.05), and greater than that in group C and Z, respectively (all *P *\< 0.05). The Cr and BUN concentrations, ALT and AST activities, and lung EB contents in group SS were significantly lower than that in group LZ (all *P *\< 0.05), and greater than that in groups C and Z, respectively (all *P *\< 0.05). There were no significant differences in six indices between the C group and the Z group (all *P *\> 0.05).Table 2Comparisons of the Cr and BUN concentrations, ALT and AST activities, and EB contents among four groups $\documentclass[12pt]{minimal}
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\begin{document}$$ (\bar{x} \pm s,\;n = 20) $$\end{document}$Cr(μmol/L)BUN (mmol/L)ALT (U/L)AST (U/L)EB (ng/mg)CO (mg/L)C92.4 ± 12.3\*5.9 ± 1.3\*37.7 ± 7.3\*49.1 ± 9.1\*46.7 ± 9.5\*0.45 ± 0.06\*Z94.9 ± 11.7\*6.1 ± 1.2\*39.2 ± 6.9\*51.6 ± 8.7\*48.2 ± 8.7\*0.43 ± 0.08\*SS120.8 ± 19.111.5 ± 2.666.9 ± 12.0105.3 ± 12.2230.4 ± 44.80.84 ± 0.14LZ135.5 ± 20.8\*13.4 ± 2.0\*77.1 ± 12.8\*115.1 ± 14.9\*270.6 ± 51.9\*0.70 ± 0.11\*\* Indicates test group significantly different from SS group (one-way ANOVA, *P *\< 0.05)

Comparisons of MDA contents and SOD activity {#Sec16}
--------------------------------------------

The comparisons of the MDA contents and SOD activity in kidney, lung and liver among four groups is shown in Table [3](#Tab3){ref-type="table"}. The nephric, pulmonary, and hepatic MDA contents in groups SS were significantly lower than that in the LZ group (all *P *\< 0.05), and greater than that in the groups C and Z (all *P *\< 0.05). The SOD activity was reverse in the four groups, respectively. There were no significant differences in MDA contents and SOD activity between groups C and Z (all *P *\> 0.05).Table 3Comparisons of the MDA contents and SOD activity in kidney, lung, and liver among four groups $\documentclass[12pt]{minimal}
\usepackage{amsmath}
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\begin{document}$$ (\bar{x} \pm s,\;n = 20) $$\end{document}$CZSSLZKidney MDA (nmol/mg protein)1.57 ± 0.54\*1.59 ± 0.51\*2.63 ± 0.663.57 ± 0.78\* SOD (NU/mg protein)28.4 ± 2.12\*27.7 ± 2.38\*14.4 ± 1.8912.2 ± 1.67\*Lung MDA (nmol/mg protein)1.79 ± 0.55\*1.83 ± 0.52\*3.62 ± 0.924.33 ± 1.12\* SOD (NU/mg protein)30.9 ± 4.4\*31.2 ± 4.1\*16.8 ± 2.0414.2 ± 1.84\*Liver MDA (nmol/mg protein)9.76 ± 1.27\*10.1 ± 1.12\*15.5 ± 2.317.4 ± 2.9\* SOD (NU/mg protein)68.1 ± 12.9\*66.4 ± 13.5\*42.1 ± 10.332.6 ± 7.2\*\* Indicates test group significantly different from SS group (1-way ANOVA, *P *\< 0.05)

Comparisons of HO-1 mRNA, HO-2 mRNA, HO-1 protein, and HO-2 protein expression {#Sec17}
------------------------------------------------------------------------------

The comparisons of HO-1 mRNA, HO-2 mRNA, HO-1 protein, and HO-2 protein in femoral arterial, nephric, pulmonary, and hepatic tissue are shown in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}, and Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"} and [8](#Fig8){ref-type="fig"}. The HO-1 mRNA and HO-1 protein of femoral arterial, nephric, pulmonary, and hepatic tissue in groups LZ were lower than that in group SS (all *P *\< 0.05), and greater than that in groups C and Z (all *P *\< 0.05). There were no significant differences between groups C and Z (all *P *\> 0.05). The HO-2 mRNA and HO-2 protein among four groups were not significantly different (all *P *\> 0.05).Table 4The comparison of HO-1mRNA and HO-2mRNA expression in the femoral arterial, hepatic, renal, and pulmonary tissue among four groups $\documentclass[12pt]{minimal}
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\begin{document}$$ (\bar{x} \pm s,\;n = 20) $$\end{document}$HO-1mRNAHO-2mRNACZSSLZCZSSLZFemoral artery0.73 ± 0.10\*0.71 ± 0.09\*1.46 ± 0.14\*1.10 ± 0.160.97 ± 0.080.99 ± 0.081.02 ± 0.081.02 ± 0.08Kidney0.81 ± 0.12\*0.79 ± 0.10\*1.33 ± 0.15\*1.07 ± 0.131.02 ± 0.080.98 ± 0.090.97 ± 0.081.03 ± 0.09Lung0.74 ± 0.11\*0.72 ± 0.10\*1.51 ± 0.19\*1.03 ± 0.141.01 ± 0.070.99 ± 0.061.02 ± 0.070.98 ± 0.05Liver0.69 ± 0.13\*0.71 ± 0.11\*1.56 ± 0.17\*1.04 ± 0.160.99 ± 0.060.98 ± 0.051.01 ± 0.071.02 ± 0.08\* Indicates test group significantly different from LZ group (1-way ANOVA, *P *\< 0.05)Table 5The comparison of HO-1 protein and HO-2 protein expression in the femoral arterial, hepatic, renal, and pulmonary tissue among four groups $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ (\bar{x} \pm s,\;n = 20) $$\end{document}$HO-1 proteinHO-2 proteinCZSSLZCZSSLZFemoral artery4.12 ± 1.06\*\*4.17 ± 1.04\*8.53 ± 2.27\*6.51 ± 1.683.83 ± 1.133.78 ± 1.103.82 ± 1.103.92 ± 0.98Kidney3.61 ± 1.11\*3.57 ± 1.13\*6.88 ± 1.29\*5.49 ± 1.203.21 ± 1.073 .14 ± 1.003.25 ± 1.093.18 ± 1.02Lung3.93 ± 0.99\*3.89 ± 0.98\*9.78 ± 1.93\*6.97 ± 1.673.49 ± 1.073.46 ± 1.053.54 ± 1.033.58 ± 1.07Liver4.29 ± 1.13\*4.21 ± 1.16\*11.56 ± 2.17\*9.44 ± 1.563.59 ± 1.163.61 ± 1.103.72 ± 1.073.67 ± 1.11\* Indicates test group significantly different from LZ group (1-way ANOVA, *P *\< 0.05)Fig. 1Western blotting analysis of HO-1 protein in femoral arterial tissueFig. 2Western blotting analysis of HO-2 protein in femoral arterial tissueFig. 3Western blotting analysis of HO-1 protein in nephric tissueFig. 4Western blotting analysis of HO-2 protein in nephric tissueFig. 5Western blotting analysis of HO-1 protein in pulmonary tissueFig. 6Western blotting analysis of HO-2 protein in pulmonary tissueFig. 7Western blotting analysis of HO-1 protein in hepatic tissueFig. 8Western blotting analysis of HO-2 protein in hepatic tissue

Discussion {#Sec18}
==========

In the present study, the role of HO--CO on septic shock in rats was investigated. The principal finding of this study was that the upregulation of HO-1 protein followed by CO increasing could reduce the mortality during septic shock, while the hypotension partly contributing to HO-1 protein and CO has no obvious relation with it.

Immunocytochemical staining localizes an increase in HO-1 protein within smooth muscle cells of both large (aorta) and small (arterioles) blood vessels, and the induction of HO and subsequent CO could reduce vascular tone during septic shock \[[@CR12]\]. To clarify the role of HO induction in septic shock, we administered ZnPP-IX to rats that were made hypotensive by LPS. We used ZnPP-IX instead of other metalloporphyrins to inhibit HO activity because ZnPP-IX has been shown to be selective for HO over other microsomal enzymes \[[@CR13]\]. To avoid effect of ZnPP-IX on NOS activity and soluble guanylyl cyclase activity in vascular endothelial cells, ZnPP-IX was given in a dose of 10 μmol/kg \[[@CR12]\] in this study. In our experiments, ZnPP-IX abrogated the LPS-induced hypotension, and it increased the mortality. At the same time, HO-1 mRNA, and HO-1 protein in femoral artery and plasma CO dramatically decreased.

Downregulation of HO-1 protein by ZnPP-IX in septic shock was found in the liver, lung, and kidney resulting in a increasing of the end-organ dysfunctions, and meanwhile CO concentration and SOD activity reduced, and MDA contents and pulmonary vascular leakage increased. Chae and colleagues \[[@CR14]\] demonstrated that the inhibition of HO-1 with using the HO-1 inhibitor ZnPP or HO-1 siRNA resulted in a striking increase of apoptosis in the CO/TNF-alpha-treated cells. Barrera et al. \[[@CR15]\] suggested that HO-1 overexpression induced by SnCl~2~ is responsible for the attenuation of renal damage and oxidative stress induced by potassium dichromate. The protective mechanisms of HO-1 may be its augmentation of iron efflux, reflecting a role for HO-1 in modulating intracellular iron levels and regulating cell viability \[[@CR4]\]. Bilirubin and biliverdin which are two metabolites of heme degradation, act as scavengers of toxic oxygen radicals. Bilirubin is a strong antioxidant in mammals \[[@CR16]\]. CO, a metabolite of heme degradation, can negatively feed back NO generation \[[@CR4]\], which can be cytotoxic because of its strong oxidation potential.

This investigation indicated that mortality increased significantly after the septic shock rats treated by ZnPP-IX. ZnPP-IX abrogated the LPS-induced hypotension. The levels of plasma ALT, AST, Cr and BUN, MDA of liver, kidney and lung, and the lung EB contents were significantly increased, while the SOD activity of liver, kidney and lung, and CO of plasma were reduced. These results indicated that ZnPP-IX treatment could increase MAP and deteriorate the function of liver, kidney, and lung.

Taken together, the increased oxidative stress and end-organ (renal, pulmonary and hepatic) damage is related to the mortality during septic shock, while the hypotension partly contributing to HO-1 protein and CO has no obvious relation with it. These data also suggest that it is unsuitable to correct refractory hypotension by restraining the HO--CO system.
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